Authors: Giolitti, A Cucchi, P Renzetti, AR Rotondaro, L Zappitelli, S Maggi, CA

Citation: A. Giolitti et al., Molecular determinants of peptide and nonpeptide NK-2 receptor antagonistsbinding sites of the human tachykinin NK-2 receptor by site-directed mutagenesis, NEUROPHARM, 39(8), 2000, pp. 1422-1429

Authors: Renzetti, AR Catalioto, RM Criscuoli, M Cucchi, P Ferrer, C Giolitti, A Guelfi, M Rotondaro, L Warner, FJ Maggi, CA

Citation: Ar. Renzetti et al., Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK2 receptor, J PHARM EXP, 290(2), 1999, pp. 487-495

Authors: Meini, S Quartara, L Rizzi, A Patacchini, R Cucchi, P Giolitti, A Calo, G Regoli, D Criscuoli, M Maggi, CA

Citation: S. Meini et al., MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor, J PHARM EXP, 289(3), 1999, pp. 1250-1256

Authors: Renzetti, AR Catalioto, RM Carloni, C Criscuoli, M Cucchi, P Giolitti, A Zappitelli, S Rotondaro, L Maggi, CA

Citation: Ar. Renzetti et al., Effects of tyrosine289phenylalanine mutation on binding and functional properties of the human tachykinin NK2 receptor stably expressed in Chinese hamster ovary cells, BIOCH PHARM, 57(8), 1999, pp. 899-906